Research map: Two-year durability of MVA-BN vaccine-induced antibodies and the risk of Mpox breakthrough infections among high-risk populations: a prospective, longitudinal study

Back to the article

Papers in this map

  1. Detection of Monkeypox Virus in Anorectal Swabs From Asymptomatic Men Who Have Sex With Men in a Sexually Transmitted Infection Screening Program in Paris, France · Valentine Marie Ferré · 2022 · 168 citations · Cited by this paper
  2. Added value of point-of-care testing for Group A Streptococcus in community pharmacy sore throat pathways: analysis of the Wales Sore Throat Test and Treat service · 2026 · Related
  3. Mpox in people with past infection or a complete vaccination course: a global case series · Aniruddha Hazra · 2023 · 149 citations · Cited by this paper
  4. Concordance between nasopharyngeal swab and bronchoalveolar lavage PCR for respiratory viruses · 2026 · Related
  5. Mpox (Monkeypox) Virus and Its Co-Infection with HIV, Sexually Transmitted Infections, or Bacterial Superinfections: Double Whammy or a New Prime Culprit? · Baoming Liu · 2024 · 84 citations · Cited by this paper
  6. “Beyond Clinical Prediction Rules: What a Large Community Pharmacy Study Reveals About Point-of-Care Testing for Group A Streptococcus.” · 2026 · Related
  7. Monkeypox Virus Infections After 2 Preexposure Doses of JYNNEOS Vaccine — United States, May 2022–May 2024 · Sarah Anne J. Guagliardo · 2024 · 52 citations · Cited by this paper
  8. Reference-standard agreement versus clinical appropriateness: rethinking LLM evaluation in infectious diseases and clinical microbiology · 2026 · Related
  9. Decline of Mpox Antibody Responses After Modified Vaccinia Ankara–Bavarian Nordic Vaccination · Ai-ris Yonekura Collier · 2024 · 51 citations · Cited by this paper
  10. Assessment of Timing for Influenza Vaccination among Older Adults in Japan: The VENUS Study · 2026 · Related
  11. Age Distribution for T Cell Reactivity to Vaccinia Virus in a Healthy Population · Szu‐Min Hsieh · 2003 · 37 citations · Cited by this paper
  12. Transmission Pathways in Emerging Infections: Linking Clinical Presentation, Epidemiology, and Outbreak Potential in Humans · 2026 · Related
  13. Neutralization Determinants on Poxviruses · Riccardo Vernuccio · 2023 · 33 citations · Cited by this paper
  14. Pneumococcal disease outbreaks in sub-Saharan Africa: rethinking the paradigm in disease control · 2026 · Related
  15. Temporary adaptations to sexual behaviour during the mpox outbreak in 23 countries in Europe and the Americas: findings from a retrospective cross-sectional online survey · Mateo Prochazka · 2024 · 25 citations · Cited by this paper
  16. Transport delay of patient specimens undermines tuberculosis drug-resistance diagnostics: programmatic experience from a high-burden setting · 2026 · Related
  17. Monkeypox Virus Infection Stimulates a More Robust and Durable Neutralizing Antibody Response Compared to Modified Vaccinia Virus Ankara Vaccination · Christopher N. Selverian · 2024 · 16 citations · Cited by this paper
  18. Optimizing dalbavancin dosing for complicated methicillin-resistant Staphylococcus aureus infections: a multicentre population pharmacokinetic study · 2026 · Related
  19. Monkeypox virus A29L protein as the target for specific diagnosis and serological analysis · Chia-Yu Liang · 2024 · 13 citations · Cited by this paper
  20. Efficacy and safety of a radiographic severity-stratified all-oral short treatment regimen for multidrug/rifampicin-resistant tuberculosis in China: an open-label, multicentre, randomised controlled, noninferiority trial · 2026 · Related
  21. Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response · Philip George Drennan · 2025 · 12 citations · Cited by this paper
  22. Antibody Responses are Sustained 2 Years Post-Mpox Infection but not Following Modified Vaccinia Ankara–Bavarian Nordic Vaccination · Joanne Byrne · 2025 · 11 citations · Cited by this paper
  23. Short-term evolution of Mpox-specific IgG and neutralizing antibodies among individuals undergoing MVA-BN vaccination · Wang-Da Liu · 2025 · 9 citations · Cited by this paper
  24. Effect of JYNNEOS vaccination on mpox clinical progression: a case–control study · Lauren Granskog · 2025 · 9 citations · Cited by this paper
  25. Asymptomatic transmission of human mpox · Margarida Martins Mouro · 2024 · 8 citations · Cited by this paper
  26. Monkeypox virus H3L protein as the target antigen for developing neutralizing antibody and serological assay · I‐Hsiang Huang · 2025 · 8 citations · Cited by this paper
  27. Clinical features of mpox in fully vaccinated people in New South Wales, Australia: an outbreak investigation and retrospective cohort study · Ned H. Latham · 2025 · 8 citations · Cited by this paper
  28. Concurrent Sexually Transmitted Infections with Mpox Infections: A Brief Review · Jenna M Wick · 2024 · 7 citations · Cited by this paper
  29. Mpox: Exploring Epidemiology, Disease Outcomes, and Preventative Vaccination Among People with HIV During the Ongoing Outbreaks · Chloe M. Orkin · 2025 · 7 citations · Cited by this paper
  30. Clinical manifestations and viral kinetics of people with Mpox: A case series during the 2023 outbreak in Taiwan · Kai-Hsiang Stanley Chen · 2024 · 5 citations · Cited by this paper
  31. Low Specific T‐Cell Immunity Against Mpox Elicited in People With HIV‐1 and PrEP Users After Subcutaneous Vaccination Compared to Natural Infection · Olivia de la Calle‐Jiménez · 2025 · 5 citations · Cited by this paper
  32. Sero-genomic evidence for occult mpox exposure in healthy Nigerian adults · Adam Abdullahi · 2026 · 5 citations · Cited by this paper
  33. Immunogenicity and safety of MVA-BN vaccine administered 5 years after a two-dose primary series in DR Congo: a prospective cohort study · Lalita Priyamvada · 2026 · 5 citations · Cited by this paper
  34. A Humoral Dilemma: Reassessing Monkeypox Virus Neutralizing Antibodies at More Than 2 Years From Mpox or Modified Vaccinia Ankara-Bavarian Nordic Vaccination · Nicolò Moschetta · 2026 · 4 citations · Cited by this paper
  35. Screening for asymptomatic mpox in at-risk populations: A cross-sectional study · Inés Armenteros Yeguas · 2025 · 3 citations · Cited by this paper
  36. Serum Mpox-specific IgG titers before and after breakthrough Mpox infection in an HIV-infected individual with viral suppression and prior 2-dose Mpox vaccination · Wang-Da Liu · 2024 · 2 citations · Cited by this paper
  37. Disproportionate presentation of Mpox among people with HIV: A multicenter retrospective cohort study in Taiwan · Po-Liang Chen · 2025 · 2 citations · Cited by this paper
  38. Persistent Immunity From Historic Smallpox Vaccination and Its Limited Cross-Neutralization of Monkeypox Virus: A Population-based Serological Study in Taiwan · An-Yu Chen · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)